Aggarwal N, Sloane BF (2014) Cathepsin B: multiple roles in cancer. PROTEOMICS–Clinical Appl 8(5–6):427–437

Article  CAS  Google Scholar 

AL MM, Lakkis ZS, Ansari ZA, Cherukuri AR, Abou-Daya KI (2024) The transformative potential of artificial intelligence in solid organ transplantation. Front Transpl, 31361491

Bagacean C, Tomuleasa C, Tempescul A, Grewal R, Brooks WH, Berthou C, Renaudineau Y (2019) Apoptotic resistance in chronic lymphocytic leukemia and therapeutic perspectives. Crit Rev Clin Lab Sci 56(5):321–332

Article  CAS  PubMed  Google Scholar 

Baig S, Seevasant I, Mohamad J, Mukheem A, Huri HZ, Kamarul T (2016) Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand? Cell Death Dis, Vol. 7 No. 1, p. e2058

Bradley CJ, Given CW, Roberts C (2001) Disparities in cancer diagnosis and survival. Cancer 91(1):178–188

Article  CAS  PubMed  Google Scholar 

CHO WC (2007) OncomiRs: the discovery and progress of MicroRNAs in cancers. Mol Cancer, 660

Crudele F, Bianchi N, Reali E, Galasso M, Agnoletto C, Volinia S (2020) The network of non-coding RNAs and their molecular targets in breast cancer. Mol Cancer 19(1):61

Article  PubMed  PubMed Central  Google Scholar 

Droga-Mazovec G, Bojič L, Petelin A, Ivanova S, Repnik U, Salvesen GS, Turk B (2008) Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues. J Biol Chem 283(27):19140–19150

Article  CAS  PubMed  Google Scholar 

Fan L, Strasser-Weippl K, Li JJ, ST LJ, Finkelstein DM, Yu KD, Chen WQ, Shao ZM, Goss PE (2014) Breast cancer in China. Lancet Oncol 15(7):e279–e289

Article  PubMed  Google Scholar 

Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, Ji X, Liu W, Huang B, Luo W, Liu B, Lei Y, Du S, Vuppalapati A, Luu HH, Haydon RC, He TC, Ren G (2018) Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis 5(2):77–106

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fridrichova I, Zmetakova I (2019) MicroRNAs contribute to breast cancer invasiveness. Cells, 8 11, pp

Fu W, Gao Y, Chen Z, Hu S (2024) Tumor immune microenvironment of colorectal cancer identifies novel prognostic signature and potential therapeutic drugs. Cancer Biomark 41(3):CBM240110

PubMed  Google Scholar 

Gocheva V, Zeng W, Ke D, Klimstra D, Reinheckel T, Peters C, Joyce JA (2006) Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev 20(5):543–556

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grassilli S, Bertagnolo V, Brugnoli F (2022) Mir-29b in breast cancer: A promising target for therapeutic approaches. Diagnostics (Basel), 12 9, pp

Jiang X, Shapiro DJ (2014) The immune system and inflammation in breast cancer. Mol Cell Endocrinol 382(1):673–682

Article  CAS  PubMed  Google Scholar 

Jovanovic M, Hengartner MO (2006) MiRNAs and apoptosis: RNAs to die for, Oncogene. 25(46):6176–6187

Kågedal K, Johansson U, Ollinger K (2001) The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J 15(9):1592–1594

Article  PubMed  Google Scholar 

Kahm YJ, Kim IG, Kim RK (2023) RanBP1: A Potential Therapeutic Target for Cancer Stem Cells in Lung Cancer and Glioma, Int J Mol Sci, Vol. 24 No. 7, pp

Kalinowski L, Saunus JM, Mccart RA, Lakhani SR (2019) Breast cancer heterogeneity in primary and metastatic disease. Adv Exp Med Biol, Vol. 115275–115104

Kirmizis A, Bartley SM, Farnham PJ (2003) Identification of the polycomb group protein SU(Z)12 as a potential molecular target for human cancer therapy. Mol Cancer Ther 2(1):113–121

CAS  PubMed  Google Scholar 

Lei S, Zheng R, Zhang S, Chen R, Wang S, Sun K, Zeng H, Wei W, He J (2021a) Breast cancer incidence and mortality in women in china: Temporal trends and projections to 2030. Cancer Biol Med 18(3):900–909

Article  PubMed  PubMed Central  Google Scholar 

Lei S, Zheng R, Zhang S, Wang S, Chen R, Sun K, Zeng H, Zhou J, Wei W (2021b) Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020. Cancer Commun (Lond) 41(11):1183–1194

Article  PubMed  Google Scholar 

Loh HY, Norman BP, Lai KS, Rahman N, Alitheen N, Osman MA (2019) The regulatory role of MicroRNAs in breast cancer. Int J Mol Sci, 20 19, pp

Nagini S (2017) Breast cancer: current molecular therapeutic targets and new players. Anticancer Agents Med Chem 17(2):152–163

Article  CAS  PubMed  Google Scholar 

Ochoa D, Jarnuczak AF, Vieitez C, Gehre M, Soucheray M, Mateus A, Kleefeldt AA, Hill A, Garcia-Alonso L, Stein F, Krogan NJ, Savitski MM, Swaney DL, Vizcaino JA, Noh KM, Beltrao P (2020) The functional landscape of the human phosphoproteome. Nat Biotechnol 38(3):365–373

Article  CAS  PubMed  Google Scholar 

Phillips MR, Zhang J, Shi Q, Song Z, Ding Z, Pang S, Li X, Zhang Y, Wang Z (2009) Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey. Lancet 373(9680):2041–2053

Article  PubMed  Google Scholar 

Qin SY, Cheng YJ, Lei Q, Zhang AQ, Zhang XZ (2018) Combinational strategy for high-performance cancer chemotherapy. Biomaterials, Vol. 171178–171197

Rahmani F, Ferns GA, Talebian S, Nourbakhsh M, Avan A, Shahidsales S (2020) Role of regulatory MiRNAs of the PI3K/AKT signaling pathway in the pathogenesis of breast cancer. Gene, 737144459

Rivenbark AG, O’connor SM, Coleman WB (2013) Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine. Am J Pathol 183(4):1113–1124

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rohini M, Gokulnath M, Miranda PJ, Selvamurugan N (2018) miR-590–3p inhibits proliferation and promotes apoptosis by targeting activating transcription factor 3 in human breast cancer cells. Biochimie 154:10–18

Article  CAS  PubMed  Google Scholar 

Rupaimoole R, Calin GA, Lopez-Berestein G, Sood AK (2016) MiRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discov 6(3):235–246

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sheng C, Qiu J, Wang Y, He Z, Wang H, Wang Q, Huang Y, Zhu L, Shi F, Chen Y, Xiong S, Xu Z, NI Q (2018) Knockdown of Ran GTPase expression inhibits the proliferation and migration of breast cancer cells. Mol Med Rep 18(1):157–168

CAS  PubMed  PubMed Central  Google Scholar 

Tang J, Ahmad A, Sarkar FH (2012) The role of MicroRNAs in breast cancer migration, invasion and metastasis. Int J Mol Sci 13(10):13414–13437

Article  CAS  PubMed  PubMed Central  Google Scholar 

Torkashvand S, Damavandi Z, Mirzaei B, Tavallaei M, Vasei M, Mowla SJ (2016) Decreased expression of bioinformatically predicted piwil2-targetting micrornas, miR-1267 and miR-2276 in breast cancer. Arch Iran Med 19(6):420–425

CAS  PubMed  Google Scholar 

Vosgha H, Salajegheh A, Smith RA, Lam AK (2014) The important roles of miR-205 in normal physiology, cancers and as a potential therapeutic target. Curr Cancer Drug Targets 14(7):621–637

Article  CAS  PubMed  Google Scholar 

Wang X, Ding Y, Wang J, Wu Y (2019) Identification of the key factors related to bladder cancer by lncRNA-miRNA-mRNA Three-Layer network. Front Genet, 101398

Wang JY, Yang Y, Wang May, Xue F, Zhu A, Yang J, Chen H, Chen Q, Ye M, Wu L, H., Zhang Q (2020) Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma. Biomed Pharmacother, Vol. 121109627

Wei Z, Duan X, Li Q, Li Q, Wang Y (2021) High expression of Ran binding protein 1 predicts poor outcomes in hepatocellular carcinoma patients: a cancer genome atlas database analysis. J Gastrointest Oncol 12(6):2966–2984

Article  PubMed  PubMed Central  Google Scholar 

Wilkinson L, Gathani T (2022) Understanding breast cancer as a global health concern. Br J Radiol 95(1130):20211033

Article  PubMed  Google Scholar 

Wu Y, He S, Cao M, Teng Y, Li Q, Tan N, Wang J, Zuo T, Li T, Zheng Y, Xia C, Chen W (2024) Comparative analysis of cancer statistics in China and the united States in 2024. Chin Med J (Engl) 137:3093–3100

Article  PubMed  Google Scholar 

Xiao Y, Humphries B, Yang C, Wang Z (2019) MiR-205 dysregulations in breast cancer: the complexity and opportunities. Noncoding RNA, 5 4, pp

Yaacoub K, Pedeux R, Tarte K, Guillaudeux T (2016) Role of the tumor microenvironment in regulating apoptosis and cancer progression. Cancer Lett 378(2):150–159

Article  CAS  PubMed  Google Scholar 

Yan B, Guo Q, Fu FJ, Wang Z, Yin Z, Wei YB, Yang JR (2015) The role of miR-29b in cancer: regulation, function, and signaling. Onco Targets Ther, Vol. 8539–8548

Yersal O, Barutca S (2014) Biological subtypes of breast cancer: prognostic and therapeutic implications. World J Clin Oncol 5(3):412–424

Article  PubMed  PubMed Central  Google Scholar